Novo Nordisk Responds to Deaths Linked to Unofficial Copies of Weight-Loss Medication
Copenhagen, Denmark — Pharmaceutical giant Novo Nordisk has acknowledged being aware of reports indicating that ten individuals may have died after using unauthorized compounded versions of its weight-loss medication. The company, a prominent player in the diabetes care market, also manufactures drugs for obesity management. According to Novo Nordisk, these medications were not produced or … Read more